Evidence map›Paper›PMID 34697369›Full record

ArticleScientific reports2021

Single-stranded DNA binding proteins influence APOBEC3A substrate preference.

Amber L Brown, Christopher D Collins, Secily Thompson, Margo Coxon, Tony M Mertz, Steven A Roberts

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Emerging drivers of DNA repeat expansions.Biochemical Society transactions · 2025
    Review
  5. Inactivation of GSK3β by SerCell death and differentiation · 2025
    Article
  6. APOBEC3A deaminates CTG hairpin loops to promote fragility and instability of expanded CAG/CTG repeats.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Evolvability of cancer-associated genes under APOBEC3A/B selection.bioRxiv : the preprint server for biology · 2023
    Article
  16. Article
  17. Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A.bioRxiv : the preprint server for biology · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amber L BrownSchool of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA, USA.
Christopher D CollinsSchool of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA, USA.
Secily ThompsonSchool of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA, USA.
Margo CoxonSchool of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA, USA.
Tony M MertzSchool of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA, USA.
Steven A RobertsSchool of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA, USA. Steven.Roberts2@wsu.edu.
Washington State University · US

Funding

TRAINING IN BIOTECHNOLOGY: EMPHASIS ON PROTEIN CHEMISTRYT32GM008336 · NIGMS · WASHINGTON STATE UNIVERSITY · PI CALL, DOUGLAS R. · 1989 to 2023
$8.9M
Mechanisms of genome instability induced by APOBEC Cytidine Deaminases & its impacts during cancer development - Diversity SupplementR01CA218112 · NCI · WASHINGTON STATE UNIVERSITY · PI ROBERTS, STEVEN A · 2017 to 2021
$2.2M
NCI NIH HHS R01 CA218112NIGMS NIH HHS T32 GM008336
6 · The paper itself

Abstract

The cytidine deaminase, APOBEC3A (A3A), is a prominent source of mutations in multiple cancer types. These APOBEC-signature mutations are non-uniformly distributed across cancer genomes, associating with single-stranded (ss) DNA formed during DNA replication and hairpin-forming sequences. The biochemical and cellular factors that influence these specificities are unclear. We measured A3A's cytidine deaminase activity in vitro on substrates that model potential sources of ssDNA in the cell and found that A3A is more active on hairpins containing 4 nt ssDNA loops compared to hairpins with larger loops, bubble structures, replication fork mimics, ssDNA gaps, or linear DNA. Despite pre-bent ssDNAs being expected to fit better in the A3A active site, we determined A3A favors a 4 nt hairpin substrate only 2- to fivefold over linear ssDNA substrates. Addition of whole cell lysates or purified RPA to cytidine deaminase assays more severely reduced A3A activity on linear ssDNA (45 nt) compared to hairpin substrates. These results indicate that the large enrichment of A3A-driven mutations in hairpin-forming sequences in tumor genomes is likely driven in part by other proteins that preferentially bind longer ssDNA regions, which limit A3A's access. Furthermore, A3A activity is reduced at ssDNA associated with a stalled T7 RNA polymerase, suggesting that potential protein occlusion by RNA polymerase also limits A3A activity. These results help explain the small transcriptional strand bias for APOBEC mutation signatures in cancer genomes and the general targeting of hairpin-forming sequences in the lagging strand template during DNA replication.

Indexed as

Cytidine DeaminaseDNA-Binding ProteinsDNA ReplicationDNA, Single-StrandedEnzyme ActivationGene ExpressionHumansNucleic Acid ConformationProtein BindingProteinsSubstrate SpecificityTranscription, GeneticAPOBEC3A protein, humanCytidine DeaminaseDNA-Binding ProteinsDNA, Single-StrandedProteins

Identifiers

PMID34697369
PMCPMC8546098
OpenAlexW3210573882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.